GSK shares slid -2.9% this afternoon. Here's what you need to know about the Large-CapPharmaceutical company:
-
GSK has logged a 5.8% 52 week change, compared to 22.5% for the S&P 500
-
GSK has an average analyst rating of hold and is -9.97% away from its mean target price of $39.88 per share
-
Its trailing earnings per share (EPS) is $3.74, which brings its trailing Price to Earnings (P/E) ratio to 9.6. The Health Care sector's average P/E ratio is 30.21
-
The company's forward earnings per share (EPS) is $3.94 and its forward P/E ratio is 9.1
-
The company has a Price to Book (P/B) ratio of 11.09 in contrast to the Health Care sector's average P/B ratio is 4.08
-
GSK has reported YOY quarterly earnings growth of -86.6% and gross profit margins of 0.7%
-
The company's free cash flow for the last fiscal year was $8.88 Billion and the average free cash flow growth rate is -1.5%
-
GSK's revenues have an average growth rate of -1.9% with operating expenses growing at -4.7%. The company's current operating margins stand at 21.9%